Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lee

Showing results (311-320 of 365) with videos related to

Pageof 37
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2026
Material economic hardships are associated with second-year hospitalizations after pediatric liver transplantation: Results from the SOCIAL-Tx studySusan A Gutierrez, Nitika Gupta, Evelyn Hsu, et al.
Cancer|April 25, 2025
Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancerSeohyuk Lee, Chao Ma, Bette J Caan, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonistNicholas Stock, Deborah Volkots, Karin Stebbins, et al.
JAMA Psychiatry|March 21, 2014
Activation, self-management, engagement, and retention in behavioral health care: a randomized clinical trial of the DECIDE interventionMargarita Alegría, Nicholas Carson, Michael Flores, et al.
Breast Cancer Research and Treatment|February 16, 2026
Neoadjuvant therapy with an aromatase inhibitor and durvalumab in postmenopausal patients with hormone receptor-positive breast cancerAixa E Soyano Muller, Dawn N Goodridge, Qianxing Mo, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2009
Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitisBrian A Stearns, Christopher Baccei, Gretchen Bain, et al.
Journal of Medicinal Chemistry|November 9, 2011
5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitorNicholas S Stock, Gretchen Bain, Jasmine Zunic, et al.
European Journal of Pharmacology|June 4, 2010
Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammationDaniel S Lorrain, Gretchen Bain, Lucia D Correa, et al.
Cancer Medicine|September 30, 2021
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropeniaJames Sun, Xiaojun Zhong, Junjie Ma, et al.
Nature Communications|January 20, 2019
Lsd1 as a therapeutic target in Gfi1-activated medulloblastomaCatherine Lee, Vasilisa A Rudneva, Serap Erkek, et al.
Pageof 37

Showing results (311-320 of 365) with videos related to

Sort By:
Pageof 37
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2026
Material economic hardships are associated with second-year hospitalizations after pediatric liver transplantation: Results from the SOCIAL-Tx studySusan A Gutierrez, Nitika Gupta, Evelyn Hsu, et al.
Cancer|April 25, 2025
Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancerSeohyuk Lee, Chao Ma, Bette J Caan, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonistNicholas Stock, Deborah Volkots, Karin Stebbins, et al.
JAMA Psychiatry|March 21, 2014
Activation, self-management, engagement, and retention in behavioral health care: a randomized clinical trial of the DECIDE interventionMargarita Alegría, Nicholas Carson, Michael Flores, et al.
Breast Cancer Research and Treatment|February 16, 2026
Neoadjuvant therapy with an aromatase inhibitor and durvalumab in postmenopausal patients with hormone receptor-positive breast cancerAixa E Soyano Muller, Dawn N Goodridge, Qianxing Mo, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2009
Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitisBrian A Stearns, Christopher Baccei, Gretchen Bain, et al.
Journal of Medicinal Chemistry|November 9, 2011
5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitorNicholas S Stock, Gretchen Bain, Jasmine Zunic, et al.
European Journal of Pharmacology|June 4, 2010
Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammationDaniel S Lorrain, Gretchen Bain, Lucia D Correa, et al.
Cancer Medicine|September 30, 2021
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropeniaJames Sun, Xiaojun Zhong, Junjie Ma, et al.
Nature Communications|January 20, 2019
Lsd1 as a therapeutic target in Gfi1-activated medulloblastomaCatherine Lee, Vasilisa A Rudneva, Serap Erkek, et al.
Pageof 37